CLIA
FDA Clears Quidel Point-of-Care Lyme Disease FIA
The FDA gives the nod to Quidel's Sofia 2 Lyme Fluorescent Immunoassay (FIA), a point-of-care diagnostic test.
SEPTEMBER 5, 2018
FDA Grants CLIA Waiver for the Alere i RSV Rapid Molecular Test
First molecular test to detect RSV infection in 13 minutes or less now widely available in a broad range of ...
MARCH 7, 2017
Load more